Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia
Not Applicable
Completed
- Conditions
- Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
- Interventions
- Procedure: photoselective vaporization prostatectomy (PVP)Procedure: Transurethral resection of the prostate
- Registration Number
- NCT00908427
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
The purpose of this study is to compared the efficacy of 80W KTP photoselective laser vaporization prostatectomy (PVP) and transurethral resection of the prostate (TURP) in reducing the volume of prostate and relieving the obstruction in men with benign prostatic hyperplasia (BPH) on non-randomized controlled design.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 86
Inclusion Criteria
- Symptomatic BPH
- International Score Prostate Symptom (IPSS) of 13 or greater
- prostate volume of 30 to 100 ML
- Peak urinary flow rate (Qmax) less than 15 mL/s with a voided volume of >125 mL and a PVR <350mL
- Able to give fully informed consent
Exclusion Criteria
- Subjects with histological diagnosis of prostate cancer
- Subjects with history of chronic urinary retention
- Subjects with urethral stricture,
- Subjects with bladder neck contracture
- Subjects with urinary tract infection
- Subjects with prostate volume on TRUS of >100 mL
- Subjects with suspected neurogenic bladder dysfunction
- Subjects who, in the opinion of investigator, are not likely to complete the study for whatever reason
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 photoselective vaporization prostatectomy (PVP) PVP group 2 Transurethral resection of the prostate TURP group
- Primary Outcome Measures
Name Time Method The changes of bladder outlet obstruction index (BOOI) 6months
- Secondary Outcome Measures
Name Time Method The changes of Quality of Life (QoL) parameters 6, 12 months The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR) 6, 12 months The changes of detrusor pressure at maximum flow rate (PdetQmax)parameters 6months The changes of International Prostatic Symptom Scores (IPSS) 6, 12 months The changes of Schafer obstruction grade parameters 6months The changes of prostate volume 6, 12 months postoperative catheterization days immediate postoperative period Complications During all study periods The changes of the hemoglobin and the serum sodium and the serum PSA immediate postoperative period The change of IIEF score 6, 12 months
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of